胰腺神经内分泌肿瘤:术前MR成像特征可预测淋巴结转移
该研究纳入2009年1月至2018年6月间108例连续胰腺神经内分泌肿瘤患者,评估MR形态学与定量特征对淋巴结转移的预测价值。单因素分析中肿瘤>2 cm、Ki-67>5%、非强化模式、ADC值、主胰管扩张、胰腺萎缩、胰外肿瘤播散及各期CNR与LNM相关;多因素分析显示非强化模式(OR 6.652,95%CI 1.369–32.321)和主胰管扩张(OR 6.745,95%CI 1.379–32.991)为独立预测因子。作者认为这些影像学预测因子术前易获取,可能有助于避免漏诊高LNM风险的pNET。
要点
- 非强化模式与主胰管扩张是pNET淋巴结转移的独立预测因子
- 肿瘤>2 cm、Ki-67>5%、ADC值、胰腺萎缩及胰外播散在单因素分析中与LNM相关
- 作者认为术前易获取的影像预测因子可能有助于避免漏诊高LNM风险pNET
核心结论
- 非强化特征和主胰管扩张似乎与pNET的淋巴结转移相关;这些影像学预测因子术前易获取,可能有助于避免漏诊高LNM风险的pNET。
研究设计与样本
- 研究纳入2009年1月至2018年6月间108例连续pNET患者,评估MR形态学特征与定量数据,采用单因素和多因素logistic回归模型评估LNM预测因子。
关键影像表现/征象
- 非强化模式在单因素分析中与LNM显著相关(P<0.001),多因素分析中OR为6.652(95%CI 1.369, 32.321;P=0.019)。
- 主胰管扩张在单因素分析中与LNM显著相关(P<0.001),多因素分析中OR为6.745(95%CI 1.379, 32.991;P=0.018)。
- 单因素分析中与LNM显著相关的特征还包括肿瘤大小>2 cm(P=0.003)、Ki-67>5%(P=0.002)、ADC值(P<0.001)、胰腺萎缩(P=0.032)、胰外肿瘤播散(P=0.001)及组织学分类(P=0.006)。
- 动脉期、门脉期和延迟期CNR在单因素分析中与LNM相关(P分别为0.005、0.047和0.045)。
诊断标准与关键数值
- 多因素分析显示非强化模式预测LNM的OR为6.652(95%CI 1.369, 32.321;P=0.019)。
- 多因素分析显示主胰管扩张预测LNM的OR为6.745(95%CI 1.379, 32.991;P=0.018)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSES: Predictive factors of lymph node metastasis (LNM) in pancreatic neuroendocrine tumors (pNETs) are not well established. We sought to identify the value of MR imaging features in preoperatively predicting the lymph node metastasis of pNETs.
MATERIALS AND METHODS: In this study, we enrolled 108 consecutive patients with pNETs between January 2009 and June 2018. MR morphologic features and quantitative data were evaluated. Predictors of LNM were evaluated using univariate and multivariate logistic regression models.
RESULTS: A total of 108 patients with pNETs were finally enrolled, including 82 LNM-negative and 26 LNM-positive patients. Features significantly related to the LNM of pNETs at univariate analysis were tumor size > 2 cm (P = 0.003), Ki-67 > 5% (P = 0.002), non-enhancement pattern (P < 0.001), apparent diffusion coefficient value (P < 0.001), main pancreatic duct dilation (P < 0.001) and pancreatic atrophy (P = 0.032) and extrapancreatic tumor spread (P = 0.001), CNRs during arterial, portal and delay phase (P = 0.005, 0.047, and 0.045, respectively), and histological classification (P = 0.006). At multivariate analysis, non-enhancement pattern (P = 0.019; odds ratio, 6.652; 95% CI 1.369, 32.321) and main pancreatic duct dilation (P = 0.018; odds ratio, 6.745; 95% CI 1.379, 32.991) were independent risk factors for predicting the LNM of pNETs.
CONCLUSION: The non-enhancement characteristic and main pancreatic duct dilation appear to be linked with LNM in pNETs. These radiological predictors can be easily obtained preoperatively, and may help to avoid missing pNETs with a high risk of LNM.
引用
- Sun H, Zhou J, Liu K, et al. Pancreatic neuroendocrine tumors: MR imaging features preoperatively predict lymph node metastasis. Abdom Radiol (NY). 2019. PMID: 30539251. doi:10.1007/s00261-018-1863-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。